Home >> Features >> Tech for License >> Paracellular Drug Delivery Through Baker’s Yeast Microcapsules
Attention: open in a new window. PrintE-mail

Paracellular Drug Delivery Through Baker’s Yeast Microcapsules

advertisement:

Yeast has the ability to reversibly open up the junctions between cells to aid drug delivery. By micro-encapsulating active ingredients inside the yeast cells, this technology enhances paracellular movement of active ingredients in mucus-rich areas such as buccal, oral, nasal, vaginal, anal, and others. Application could be by means of powder, tablet, capsule, chewable tablet, chewing gum, melting film strip, spray, cream, or gel. Yeast offers an alternative to chitosan as a permeation enhancer and mucoadhesive mechanism.

It may also be possible to have a multi-drug system where a water-soluble active ingredient, formulated together with yeast cells, also has a lipophilic/water-insoluble active ingredient entrapped within those yeast cells. The technology offers new modalities for oral mucosal drug delivery; targeted delivery of a lipophilic active anywhere from the mouth to the lower bowel; topical delivery; taste-masking of volatile lipophilic flavors; better uptake in creams, gels, and ointments; improved nasal spray drug delivery; and non-invasive insulin delivery.

Get the complete report on this technology at:
www.techbriefs.com/tow/200806b.html
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Phone: 781-972-0600

Dedicated to helping you design better products in a digital world... your guide to the latest tools & techniques for digital prototyping, simulation, and analysis of the real-world performance of your ideas. Visit the Digital Design Center

>> Newsletter

Subscribe today to receive the INSIDER, a FREE e-mail newsletter from NASA Tech Briefs featuring exclusive previews of upcoming articles, late breaking NASA and industry news, hot products and design ideas, links to online resources, and much more.

Your name:

Your email:

Please Subscribe me to the Insider